Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PRTC

PureTech Health (PRTC)

PureTech Health PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateTimeSourceHeadlineSymbolCompany
28/04/202321:29Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRTCPureTech Health PLC
28/04/202320:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
28/04/202316:00Business WirePureTech Announces Annual Results for Year Ended December 31, 2022NASDAQ:PRTCPureTech Health PLC
25/04/202320:50Business WirePureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia TherapiesNASDAQ:PRTCPureTech Health PLC
17/04/202321:05Business WirePureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMIDNASDAQ:PRTCPureTech Health PLC
13/04/202316:00Business WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
05/04/202306:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
23/03/202322:00GlobeNewswire Inc.Royalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 MillionNASDAQ:PRTCPureTech Health PLC
23/03/202321:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
23/03/202318:00Business WirePureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 MillionNASDAQ:PRTCPureTech Health PLC
21/03/202302:49Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
03/03/202308:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
01/03/202323:00Business WirePureTech to Present at the Barclays Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
28/02/202301:05Business WirePureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)NASDAQ:PRTCPureTech Health PLC
14/02/202323:00Business WirePureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum DepressionNASDAQ:PRTCPureTech Health PLC
10/02/202322:10Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NASDAQ:PRTCPureTech Health PLC
03/02/202322:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
01/02/202323:00Business WirePureTech to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:PRTCPureTech Health PLC
22/12/202222:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
22/12/202218:00Business WirePureTech Provides End of Year Report on Key ProgressNASDAQ:PRTCPureTech Health PLC
19/12/202223:00Business WirePureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy VolunteersNASDAQ:PRTCPureTech Health PLC
13/12/202223:00Business WirePureTech to Present at 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
13/12/202201:00Business WirePureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual MeetingNASDAQ:PRTCPureTech Health PLC
09/12/202223:00Business WirePureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health MonitoringNASDAQ:PRTCPureTech Health PLC
03/12/202208:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
30/11/202223:00Business WirePureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ PlatformNASDAQ:PRTCPureTech Health PLC
17/11/202223:00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
11/11/202208:33Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
09/11/202223:17Business WirePureTech to Present at the Jefferies London Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
04/11/202207:57Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Your Recent History

Delayed Upgrade Clock